NCT07039318 - Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

May 31, 2025

Conditions

Diabetic Kidney Disease

Interventions

BIOLOGICAL

Mesenchymal stem cells

DRUG

Normal Saline (Placebo)

Trial Locations (2)

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan/Armed Forces Bone Marrow Transplant Centre, Rawalpindi

Pak Emirates Military Hospital, Rawalpindi (PEMH), Rawalpindi

All Listed Sponsors

collaborator

Pak Emirates Military Hospital

OTHER

lead

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

OTHER_GOV